Stock listing

Enzymatica Ab

Selected listing: EN9 · GETTEX · EUR · DE

Enzymatica Ab (gettex:EN9), Health Technology. Latest release Jun 9, 2026: Enzymatica appoints Marketing and Sales Director to accelerate ColdZyme’s continued…

EN9:GETTEXEURDEUpdated October 3, 2026

Ticker: gettex:EN9
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: gettex
Currency: EUR

Latest news from Enzymatica Ab

Enzymatica appoints Marketing and Sales Director to accelerate ColdZyme’s continued growth in the Nordics

June 9, 2026

Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement

April 28, 2026

Enzymatica publishes annual report for 2025

April 14, 2026

Enzymatica and STADA sign partnership agreement for Germany and Austria

March 31, 2026

Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion

February 18, 2026

All Enzymatica Ab news →

Research Enzymatica Ab

Enzymatica Ab company profile

View the public company page for Enzymatica Ab on 6ix.

Enzymatica Ab news

Read company news and market updates connected to Enzymatica Ab.

Enzymatica Ab investor events

Find investor webinars, events, and replay context for Enzymatica Ab.